Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al .

Autor:	Martinez Sanz P; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands p.martinezsanz@sanquin.nl., van Rees DJ; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Matlung HL; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands., Tytgat GAM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Franke K; Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.
Jazyk:	angličtina
Zdroj:	Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Dec; Vol. 9 (12).
DOI:	10.1136/jitc-2021-003983
Abstrakt:	Competing Interests: Competing interests: None declared.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu